NCT00004268View on ClinicalTrials.gov

Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 30, 2001

Conditions
Orthostatic Hypotension
Interventions
DRUG

midodrine

Trial Locations (1)

10029

Mount Sinai School of Medicine, New York

All Listed Sponsors
collaborator

Roberts Pharmaceutical

INDUSTRY

lead

National Center for Research Resources (NCRR)

NIH

NCT00004268 - Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension | Biotech Hunter | Biotech Hunter